Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and ...

The increase was largely attributed to VYVGART’s performance, along with other products like ZEJULA and NUZYRA. Additionally, Zai Lab reported a net loss improvement, reflecting efforts in financial ...

In addition to Vyvgart, NHSA has added Zai Lab’s (ZLAB) oral antibacterial therapy, Nuzyra, and renewed the inclusion of Zejula, the ovarian cancer therapy it develops with GSK (GSK), in the NRDL.

Here is how Zai Lab Limited performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Product Revenue- ZEJULA: $48.23 million versus ...

Zai Lab Ltd. is a biopharmaceutical company ... and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April ...

GSK acquired Zejula as part of its $5.1 billion takeover of Tesaro in 2018, along with other oncology drug candidates, including latecomer PD-1 inhibitor Jemperli (dostarlimab) and others ...

AstraZeneca’s ovarian cancer drug Lynparza is facing competition in Europe with Tesaro's rival Zejula now set for launch. Zejula (niraparib) has now gained final marketing approval from the the ...

Zai Lab Limited Unsponsored ADR (ZLAB) shares ended the last trading session 11.1% higher at $22.60. The jump came on an impressive volume with a higher-than-average number of shares changing ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2024, along with recent product highlights and corporate ...

Zai Lab Limited Unsponsored ADR (ZLAB) shares soared 14.7% in the last trading session to close at $33.18. The move was backed by solid volume with far more shares changing hands than in a normal ...

Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China. Oct 25 5:36am ET Zai ...